A. Mospan | Pedestal Health

5

Total Publications

5

Poster Presentation

2025 · Poster Presentation · Yes · Hepatology

Changes in The Fibrosis-4 (FIB-4) Score Accurately Reflects The Disease Trajectory of Metabolic Dysfunction Associated Steatotic Liver Disease.

2025 · Poster Presentation · Yes · Hepatology

Clinical Characteristics of Patients With Presumed MASLD Who Meet Met-ALD Criteria in the TARGET-NASH Cohort.

2024 · Poster Presentation · University of Birmingham (UK) · Hepatology

Stability of the NASH-CHECK patient-reported outcome measure over time in patients with metabolic dysfunction-associated steatotic liver disease and stable clinical status.

2024 · Poster Presentation · Yes · Hepatology

A prospective assessment of the impact of decompensation of cirrhosis on patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease.

2022 · Poster Presentation · Pharma Partner · Hepatology

Longitudinal ALT Trajectories are Generally Stable Among Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): An Investigation Using Artificial Recurrent Neural Networks.